ANNE PENMAN THERAPY LTD.
Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (83/100, director aged 73). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total assets | £18.6k | £20.7k |
| Current assets | £25.3k | £25.3k |
| Debtors | £25.3k | — |
| Net assets | £18.6k | £20.7k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (30 events)Click to expand
- 2025-09-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-08-15📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-09-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-09-01📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-08-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-12-22📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-09-12📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-07-10📄change-person-director-company-with-change-dateofficers · CH01
- 2019-07-10📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2019-07-10📄change-person-secretary-company-with-change-dateofficers · CH03
- 2018-09-25📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2017-09-08📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2016-09-07📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-10-01📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2015-09-09📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2007-08-10➕PENMAN, Ron appointedsecretary
- 2007-08-10➖PENMAN, Scott Stuart resignedsecretary
- 2007-08-10➖PENMAN, Scott Stuart resigneddirector
- 1999-11-12➕PENMAN, Scott Stuart appointedsecretary
- 1999-11-12➕PENMAN, Scott Stuart appointeddirector
- 1999-09-17➖PENMAN, Ronald Lamert resignedsecretary
- 1999-09-17➖PENMAN, Ronald Lamert resigneddirector
- 1999-08-12➕PENMAN, Anne Florence appointeddirector
- 1999-08-12➕PENMAN, Ronald Lamert appointedsecretary
- 1999-08-12➖BRIAN REID LTD. resignedcorporate-nominee-secretary
- 1999-08-12➕PENMAN, Ronald Lamert appointeddirector
- 1999-08-12➖STEPHEN MABBOTT LTD. resignedcorporate-nominee-director
- 1999-07-26🏢Company incorporatedAs ANNE PENMAN THERAPY LTD.
- 1999-07-26➕BRIAN REID LTD. appointedcorporate-nominee-secretary
- 1999-07-26➕STEPHEN MABBOTT LTD. appointedcorporate-nominee-director
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder name in company name: Company name contains director surname "PENMAN" — strong identity link between founder and business.
- +Long-tenure founder: Senior director has been in place 27 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 73 — succession pressure is live.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 70+: Senior director is approximately 73 years old. Natural succession window is now.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- primary20+ year tenure: Director in role 27 years. Very long tenure is a classic succession signal.
- secondaryStable-but-static management: Company is 27 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Anne Florence Penman Individual · British · DOB 07/1953 · age 73 | 50–75% | — | board control50-75% shares · board control | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AM NURSERY GROUP LIMITED→ SC768675 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMD MAPLE LIMITED→ SC797976 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AMIRS HEALTHCARE LIMITED→ SC633331 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ANDREW BIANKIN LTD→ SC500006 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| ANGELA HECHT THERAPY LTD→ SC714674 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ANNE MORRISON HEALTH LTD→ SC854383 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| APPLECROSS INVESTMENTS LIMITED→ SC823800 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| APPLECROSS NURSING HOME LIMITED→ SC177933 · est 1997 · no financials extracted | — | — | — | — | 28y | — | — |
| AR DENTAL LIMITED→ SC400032 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| AR HYPNO LTD→ SC797926 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ARCHEGOS MEDICAL IMAGING LIMITED→ SC812129 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ARCHWARD LIMITED→ SC465707 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 6 resigned)
Click a director name to see their full track record across all companies.